Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherLetters to the Editor

Cooking Annexin V: A Simple 1-Pot Procedure to Destroy Its Phosphatidylserine-Binding Activity

Chris Reutelingsperger, Leo Hofstra and Jagat Narula
Journal of Nuclear Medicine June 2004, 45 (6) 1098-1099;
Chris Reutelingsperger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo Hofstra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jagat Narula
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR:

We read with interest the article by Subbarayan et al. concerning the use of annexin V to image apoptosis in vivo (1). A series of publications in 1994 and 1995 had initiated a broad interest in the use of annexin V as a tool to measure apoptosis in vitro and in vivo. Hofstra et al. (2) and Narula et al. (3) augmented this interest by demonstrating that 99mTc-annexin V scintigraphy reveals apoptosis. Subbarayan et al. described a simplified method to produce 99mTc-annexin V. One part of the procedure was the heating of annexin V at 90°C for 10 min. In 1985, we reported that heating annexin V (at that time we called it a vascular anticoagulant) destroyed its phospholipid-binding activity, which determines its ability to target apoptotic cells (4). In 1997, van den Eijnde et al., who were the first to demonstrate that annexin V can be used to visualize apoptosis in vivo, showed that heat-inactivated annexin V does not bind to apoptotic cells in vivo (5). And Dumont et al. showed that the annexin V mutant, which does not bind to phosphatidylserine, fails to bind to apoptotic cells in vivo (6). Subbarayan et al. have not reported on the phospholipid-binding activity of their 99mTc-annexin V preparation, and we have serious doubts that the 99mTc-annexin V produced using their protocol would retain the potency to bind to apoptotic cells in vivo.

REFERENCES

  1. ↵
    Subbarayan M, Häfeli UO, Feyes DK, Unnithan J, Emancipator SN, Mukhtar H. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med. 2003;44:650–656.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209–212.
    OpenUrlCrossRefPubMed
  3. ↵
    Narula J, Acio ER, Narula N, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med. 2001;7:1347–1352.
    OpenUrlCrossRefPubMed
  4. ↵
    Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem. 1985;151:625–629.
    OpenUrlPubMed
  5. ↵
    van den Eijnde SM, Boshart L, et al. Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ. 1997;4:311–316.
    OpenUrlCrossRefPubMed
  6. ↵
    Dumont EA, Reutelingsperger CP, Smits JF, et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med. 2001;7:1352–1355.
    OpenUrlCrossRefPubMed

REPLY:

We appreciate the comments of Reutelingsperger et al. We are aware of their cited references, which show that heat inactivation of annexin V prevents the protein from binding to phosphatidylserine and thus also from binding to apoptotic cells. Knowing this, we agree that it was quite bold of us to have even attempted the radiolabeling of annexin V with a method that used a temperature of 90°C for 10 min, as described in our paper (1). Thin-layer and size-exclusion chromatography confirmed that we had prepared the radiolabeled annexin V complex. We did not, however, test its phospholipid-binding properties, which could be done, for example, using the method described by Verbeke et al. (2). Our approach was instead to test the apoptosis-detecting properties of radiolabeled annexin V in tumor-bearing mice that had undergone photodynamic therapy 1 h before the annexin V application. That tumor uptake was rapid and significant is evident from Figures 4 and 5 of our paper (1). If the assertion of Reutelingsperger at al. that we destroyed the phosphatidylserine-binding properties of annexin V is true, then what accounts for our successful imaging? Could we have produced a 99mTc-complex—other than the annexin V—that found its way into the tumor? We sterile-filtrated the annexin V before injection, and such a complex would thus have at least been smaller than 0.22 μm. We did not, however, see any precipitate. Or could it have been that the additionally added compounds during the labeling, such as succinic dihydrazide, nicotinic acid, tricine, and propylenediaminetetraacetic acid, protected the annexin V molecule from degradation? Further research would be necessary to answer these questions.

We have additional indications, obtained by a completely different set of experiments, that our method is able to produce a radiolabeled species that can detect apoptosis. In these, we used an in vitro cell culture system to grow melanoma cancer cells in 6-well plates. Both the right and the middle wells were incubated for 3 h with the photosensitizer Pc 4 (0.5 μmol/L), whereas the left well received no Pc 4. All wells were then subjected to photodynamic therapy. Three hours later, 4.8 MBq of the 99mTc-labeled annexin V were added to the left and middle wells, whereas the right wells received 4.8 MBq of 99mTc in the form of pertechnetate. One hour later, the cells were washed and placed on a phosphor screen, and autoradiography was performed. As seen in Figure 1, the cells without the radiosensitizer showed no significant radioactivity uptake, in stark contrast to the cells that received the photodynamic therapy. Replacing the radiolabeled annexin V with 99mTc-pertechnetate showed no retention of radioactivity. Microscopic pictures confirmed that the nonirradiated tumor cells looked healthy whereas most of the irradiated cells were in the process of undergoing apoptosis. We have observed the same behavior not only in the melanoma cancer cells shown in Figure 1 but also in A431 human epidermoid carcinoma cells and PC3 prostate cancer cells.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

In vitro experiment with B16 melanoma cancer cells to detect apoptosis after photodynamic therapy. Wells B and C were incubated with the photosensitizer Pc 4, and all wells were then irradiated with laser light of 672 nm (15 kJ/cm2). One hour later, 4.8 MBq of 99mTc-annexin V was added to wells A and B, whereas well C received 4.8 MBq of 99mTc-pertechnetate. After 1 h of incubation, the wells were washed and autoradiography was performed. The cells treated with light in the absence of photosensitizer show only minor radioactivity uptake (A) and look healthy under the microscope (D). The cells treated with light in the presence of the photosensitizer show avid 99mTc-annexin V uptake (B) but no 99mTc-pertechnetate uptake (C), although their corresponding photomicrographs (E and F) show that almost every cell was undergoing apoptosis.

REFERENCE

  1. ↵
    Subbarayan M, Häfeli UO, Feyes DK, Unnithan J, Emancipator SN, Mukhtar H. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med. 2003;44:650–656.
  2. ↵
    Verbeke K, Kieffer D, Vanderheyden JL, et al. Optimization of the preparation of 99mTc-labeled Hynic-derivatized annexin V for human use. Nucl Med Biol. 2003;30:771–778.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 45 (6)
Journal of Nuclear Medicine
Vol. 45, Issue 6
June 1, 2004
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cooking Annexin V: A Simple 1-Pot Procedure to Destroy Its Phosphatidylserine-Binding Activity
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cooking Annexin V: A Simple 1-Pot Procedure to Destroy Its Phosphatidylserine-Binding Activity
Chris Reutelingsperger, Leo Hofstra, Jagat Narula
Journal of Nuclear Medicine Jun 2004, 45 (6) 1098-1099;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cooking Annexin V: A Simple 1-Pot Procedure to Destroy Its Phosphatidylserine-Binding Activity
Chris Reutelingsperger, Leo Hofstra, Jagat Narula
Journal of Nuclear Medicine Jun 2004, 45 (6) 1098-1099;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
    • REFERENCE
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Redefining Nuclear Medicine: “Biodistribution” Should Be the Core Concept
  • 176Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety
  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
Show more Authors of the Letter and the Reply

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire